the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Malaysia to keep playing constructive role in strengthening ASEAN

PM Anwar Ibrahim reaffirms Malaysia’s commitment to a resilient and inclusive ASEAN during a meeting with the ASEAN secretary-general.

KUALA LUMPUR: Malaysia will continue to play a constructive role in strengthening ASEAN as a resilient, inclusive community capable of meeting the aspirations of its people, Prime Minister Datuk Seri Anwar Ibrahim said today.

In a Facebook post, Anwar said he reaffirmed Malaysia’s commitment during a courtesy call by ASEAN Secretary-General Dr Kao Kim Hourn after delivering the keynote address and participating in a question-and-answer session at the 39th Asia-Pacific Roundtable (APR) here.

Anwar, who is also Finance Minister, said the meeting provided an opportunity to exchange views on regional issues and ASEAN’s priorities in navigating an increasingly challenging geopolitical and economic landscape.

“We also discussed developments in Myanmar, the situation in the South China Sea, advances in artificial intelligence (AI), the post-accession phase following Timor-Leste’s full membership in ASEAN, the implementation of the ASEAN Community Vision 2045, as well as the implications of the conflict in West Asia on the region,” he said.

Anwar also stressed that ASEAN must continue to uphold the principles of unity, centrality and close cooperation to ensure the region remains peaceful, stable and prosperous.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings